Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on June 21, 2006
J Am Soc Nephrol 17: 2275-2284, 2006
© 2006 American Society of Nephrology
doi: 10.1681/ASN.2005121273

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2005121273v1
17/8/2275    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hallan, S. I.
Right arrow Articles by Holmen, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hallan, S. I.
Right arrow Articles by Holmen, J.
Related Collections
Right arrowRelated Articles

Epidemiology and Outcomes

International Comparison of the Relationship of Chronic Kidney Disease Prevalence and ESRD Risk

Stein I. Hallan*,{dagger}, Josef Coresh{ddagger},§, Brad C. Astor{ddagger}, Arne Åsberg||, Neil R. Powe{ddagger},§, Solfrid Romundstad,**, Hans A. Hallan, Stian Lydersen{dagger} and Jostein Holmen**

* Department of Medicine, Division of Nephrology, and || Department of Medical Biochemistry, St. Olav University Hospital, and {dagger} Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; {ddagger} Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, and § Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Medicine, Levanger Hospital, Levanger, Norway; and ** HUNT Research Centre, Faculty of Medicine, Norwegian University of Science and Technology, Verdal, Norway

Address correspondence to: Dr. Stein I. Hallan, Department of Medicine, Division of Nephrology, St. Olav University Hospital, N-7006 Trondheim, Norway. Phone: +47-73867472; Fax: +47-73869390; stein.hallan{at}ntnu.no

Received for publication December 9, 2005. Accepted for publication May 5, 2006.

ESRD incidence is much lower in Europe compared with the United States. This study investigated whether this reflects a difference in the prevalence of earlier stages of chronic kidney disease (CKD) or other mechanisms. CKD prevalence in Norway was estimated from the population-based Health Survey of Nord-Trondelag County (HUNT II), which included 65,181 adults in 1995 through 1997 (participation rate 70.4%). Data were analyzed using the same methods as two US National Health and Nutrition Examination Surveys in 1988 through 1994 (n = 15,488) and 1999 through 2000 (n = 4101). The primary analysis used gender-specific cutoffs in estimating persistent albuminuria for CKD stages 1 and 2. ESRD rates and other relevant data were extracted from national registries. Total CKD prevalence in Norway was 10.2% (SE 0.5): CKD stage 1 (GFR >90 ml/min per 1.73 m2 and albuminuria), 2.7% (SE 0.3); stage 2 (GFR 60 to 89 ml/min per 1.73 m2 and albuminuria), 3.2% (SE 0.4); stage 3 (GFR 30 to 59 ml/min per 1.73 m2), 4.2% (SE 0.1); and stage 4 (GFR 15 to 29 ml/min per 1.73 m2), 0.2% (SE 0.01). This closely approximates reported US CKD prevalence (11.0% in 1988 through 1994 and 11.7% in 1999 through 2000). The relative risk for progression from CKD stages 3 or 4 to ESRD in US white patients compared with Norwegian patients was 2.5. This was only modestly modified by adjustment for age, gender, and diabetes. Age and GFR at start of dialysis were similar, hypertension and cardiovascular mortality in the populations were comparable, but US white patients were referred later to a nephrologist and had higher prevalence of obesity and diabetes. In conclusion, CKD prevalence in Norway was similar to that in the United States, suggesting that lower progression to ESRD rather than a smaller pool of individuals at risk accounts for the lower incidence of ESRD in Norway.


Related Articles

Risk for Progression to ESRD: Further Evidence from Population-Based Studies
Haimanot Wasse and William McClellan
J. Am. Soc. Nephrol. 2006 17: 2092-2093. [Full Text] [PDF]

Chronic Kidney Disease Prevalence and Treated End-Stage Renal Disease Incidence: A Complex Relationship
Bénédicte Stengel and Cécile Couchoud
J. Am. Soc. Nephrol. 2006 17: 2094-2096. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
E. K. Sumaili, J.-M. Krzesinski, C. V. Zinga, E. P. Cohen, P. Delanaye, S. M. Munyanga, and N. M. Nseka
Prevalence of chronic kidney disease in Kinshasa: results of a pilot study from the Democratic Republic of Congo
Nephrol. Dial. Transplant., January 1, 2009; 24(1): 117 - 122.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
O. Moranne, M. Froissart, J. Rossert, C. Gauci, J.-J. Boffa, J. P. Haymann, M. B. M'rad, C. Jacquot, P. Houillier, B. Stengel, et al.
Timing of Onset of CKD-Related Metabolic Complications
J. Am. Soc. Nephrol., January 1, 2009; 20(1): 164 - 171.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. Ishani, J. L. Xue, J. Himmelfarb, P. W. Eggers, P. L. Kimmel, B. A. Molitoris, and A. J. Collins
Acute Kidney Injury Increases Risk of ESRD among Elderly
J. Am. Soc. Nephrol., January 1, 2009; 20(1): 223 - 228.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
R. T. Gansevoort and E. Ritz
Hermann Senator and albuminuria--forgotten pioneering work in the 19th century
Nephrol. Dial. Transplant., December 10, 2008; (2008) gfn741v1.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
W. Chen, W. Chen, H. Wang, X. Dong, Q. Liu, H. Mao, J. Tan, J. Lin, F. Zhou, N. Luo, et al.
Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China
Nephrol. Dial. Transplant., October 24, 2008; (2008) gfn604v1.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S.-J. Hwang, M.-Y. Lin, H.-C. Chen, S.-C. Hwang, W.-C. Yang, C.-C. Hsu, H.-C. Chiu, and L.-W. Mau
Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan
Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3192 - 3198.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
P. E. de Jong and R. T. Gansevoort
Fact or fiction of the epidemic of chronic kidney disease--let us not squabble about estimated GFR only, but also focus on albuminuria
Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1092 - 1095.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
R. J. Glassock and C. Winearls
An epidemic of chronic kidney disease: fact or fiction?
Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1117 - 1121.
[Full Text] [PDF]


Home page
CJASNHome page
P. E. de Jong, M. van der Velde, R. T. Gansevoort, and C. Zoccali
Screening for Chronic Kidney Disease: Where Does Europe Go?
Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 616 - 623.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
R. Calderon-Margalit, E.-S. Gordon, M. Hoshen, J. D. Kark, A. Rotem, and Z. Haklai
Dialysis in Israel, 1989-2005--time trends and international comparisons
Nephrol. Dial. Transplant., February 1, 2008; 23(2): 659 - 664.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
N. Bassilios, P. Martel, V. Godard, M. Froissart, J.-P. Grunfeld, B. Stengel, and on behalf of the Reseau Nephropar
Monitoring of glomerular filtration rate in lithium-treated outpatients--an ambulatory laboratory database surveillance
Nephrol. Dial. Transplant., February 1, 2008; 23(2): 562 - 565.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
N.M.P. Annear, D. Banerjee, J. Joseph, T.H. Harries, S. Rahman, and J.B. Eastwood
Prevalence of chronic kidney disease stages 3-5 among acute medical admissions: another opportunity for screening
QJM, February 1, 2008; 101(2): 91 - 97.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
S. R. Orth and S. I. Hallan
Smoking: A Risk Factor for Progression of Chronic Kidney Disease and for Cardiovascular Morbidity and Mortality in Renal Patients Absence of Evidence or Evidence of Absence?
Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 226 - 236.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
S. Hallan, B. Astor, S. Romundstad, K. Aasarod, K. Kvenild, and J. Coresh
Association of Kidney Function and Albuminuria With Cardiovascular Mortality in Older vs Younger Individuals: The HUNT II Study
Arch Intern Med, December 10, 2007; 167(22): 2490 - 2496.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. S. MacGregor
How common is early chronic kidney disease?: A Background Paper prepared for the UK Consensus Conference on Early Chronic Kidney Disease
Nephrol. Dial. Transplant., September 1, 2007; 22(suppl_9): ix8 - ix18.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
F. Caskey, R. Steenkamp, and D. Ansell
International comparison of UK registry data (Chapter 17)
Nephrol. Dial. Transplant., August 1, 2007; 22(suppl_7): vii185 - vii193.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
T. D. DuBose Jr.
American Society of Nephrology Presidential Address 2006: Chronic Kidney Disease as a Public Health Threat--New Strategy for a Growing Problem
J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1038 - 1045.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
W. G. Couser, S. Shah, and For the joint international Society of Nephrology/
A call to action on World Kidney Day, 8 March 2007
Nephrol. Dial. Transplant., March 1, 2007; 22(3): 676 - 677.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
K. J. Jager and P. C. W. van Dijk
Has the rise in the incidence of renal replacement therapy in developed countries come to an end?
Nephrol. Dial. Transplant., March 1, 2007; 22(3): 678 - 680.
[Full Text] [PDF]


Home page
CJASNHome page
C.-y. Hsu, A. S. Go, C. E. McCulloch, J. Darbinian, and C. Iribarren
Exploring Secular Trends in the Likelihood of Receiving Treatment for End-Stage Renal Disease
Clin. J. Am. Soc. Nephrol., January 1, 2007; 2(1): 81 - 88.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
P. Ruggenenti and G. Remuzzi
Kidney Failure Stabilizes after a Two-Decade Increase: Impact on Global (Renal and Cardiovascular) Health
Clin. J. Am. Soc. Nephrol., January 1, 2007; 2(1): 146 - 150.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
H. Wasse and W. McClellan
Risk for Progression to ESRD: Further Evidence from Population-Based Studies
J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2092 - 2093.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
B. Stengel and C. Couchoud
Chronic Kidney Disease Prevalence and Treated End-Stage Renal Disease Incidence: A Complex Relationship
J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2094 - 2096.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP